Cellectis (CLLS) Cash & Equivalents Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -12.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.68% |
| Dec 31, 2025 | -12.93% |
| Sep 30, 2025 | 13.63% |
| Jun 30, 2025 | -22.69% |
| Mar 31, 2025 | -6.24% |
| Dec 31, 2024 | -8.28% |
| Sep 30, 2024 | -13.43% |
| Jun 30, 2024 | -18.03% |
| Mar 31, 2024 | -17.24% |
| Dec 31, 2023 | -17.24% |
| Sep 30, 2023 | -29.05% |
| Jun 30, 2023 | -37.19% |
| Mar 31, 2023 | -33.74% |
| Dec 31, 2022 | -35.07% |
| Sep 30, 2022 | -34.18% |
| Jun 30, 2022 | -34.06% |
| Mar 31, 2022 | -28.37% |
| Dec 31, 2021 | -25.64% |
| Sep 30, 2021 | -23.78% |
| Jun 30, 2021 | -19.24% |
| Mar 31, 2021 | -2.02% |
| Dec 31, 2020 | -2.02% |
| Sep 30, 2020 | -0.37% |
| Jun 30, 2020 | 10.18% |
| Mar 31, 2020 | 4.09% |
| Dec 31, 2019 | 9.30% |
| Sep 30, 2019 | 0.04% |
| Jun 30, 2019 | 8.34% |
| Mar 31, 2019 | 6.73% |
| Dec 31, 2018 | 9.44% |
| Sep 30, 2018 | 56.15% |
| Jun 30, 2018 | 55.98% |
| Mar 31, 2018 | 26.41% |
| Dec 31, 2017 | 200.51% |